CDC investigating potential exposures of American citizens to Ebola in West Africa

On March 13, an American volunteer health care worker in Sierra Leone who tested positive for Ebola virus returned to the U.S. by medevac and was admitted to the NIH Clinical Center for care and treatment.  As a result of this case, CDC is conducting contact tracing of individuals in Sierra Leone, including several other American citizens, who may have had potential exposure to this index patient.  At this time, none of these individuals have tested positive for Ebola. These individuals are volunteers in the Ebola response and are currently being monitored in Sierra Leone.  Out of an abundance of caution, CDC and the State Department are developing contingency plans for returning those Americans with potential exposure to the U.S. by non-commercial air transport. Those individuals will voluntarily self-isolate and be under direct active monitoring for the 21-day incubation period.

One of these American citizens had potential exposure to the individual being treated at NIH and is currently being transported via charter to the Atlanta area to be close to Emory University Hospital. The individual has not shown symptoms of Ebola and has not been diagnosed with Ebola. Upon arrival in Atlanta, the individual will voluntarily self-isolate and be under direct active monitoring for the 21-day incubation period.

Patient with exposure to Ebola has arrived safely at NIH Clinical Center in America

A patient with exposure to the Ebola virus in Sierra Leone has been transferred from an overseas location and admitted to the NIH Clinical Center for observation and to enroll in a clinical protocol. The patient arrived at the NIH Clinical Center on Sunday, September 28, at approximately 4 p.m. ET.

The patient is an American physician who was volunteering services in an Ebola treatment unit in Sierra Leone.

Out of an abundance of caution, the patient has been admitted to the NIH Clinical Center’s special clinical studies unit that is specifically designed to provide high-level isolation capabilities and is staffed by infectious diseases and critical care specialists. The unit staff is trained in strict infection control practices optimized to prevent spread of potentially transmissible agents such as Ebola.

No additional details about the patient are available at this time.

NIH is taking every precaution to ensure the safety of our patients, NIH staff, and the public. This situation presents minimal risk to any of them.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.